Icon

NIRAVAM (nda021726)- (0.25MG,0.5MG,1MG,2MG)

ALPRAZOLAM UCB INC
0.25MG,0.5MG,1MG,2MG
Yes Yes
2018-Apr-09 Expired
None None
None No
NIRAVAM ® is a benzodiazepine indicated for: • the treatment of generalized anxiety disorder, • the treatment of panic disorder, with or without agoraphobia.
2 0 2
Total Other Developers None
Drugs with Suitability No
0.25MG ** ** - - 2
0.5MG ** ** - - 2
1MG ** ** - - 2
2MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.